2 October – ISRAEL21c
One out of every eight women will develop breast cancer in her lifetime. It is the most commonly diagnosed non-skin cancer in women worldwide, and also strikes thousands of men.
Though the three areas with the highest breast cancer rates are Western Europe, Australia/New Zealand and Northern Europe, Israel has taken a leading role in researching causes and treatments. The Breast Cancer Research Foundation’s very first international research grant was awarded in 2001 to Shaare Zedek Medical Center’s Dr. Ephrat Levy-Lahad to do a comprehensive Israeli Breast Cancer Study, now an international model for genetic breast cancer prevention screening. Over the past 12 months, ISRAEL21c has reported on exciting news in cancer research from Israeli laboratories. We present 10 of the most promising advances here with our hope that breast cancer may soon be relegated to history.
The Israeli company Real Imaging offers a no-radiation, no-contact alternative to mammography pioneered by electro-optical engineer Boaz Arnon and named in memory of his mother, who died of breast cancer in 2004.
RUTH uses a new trademarked platform that enables automatic quantitative analysis of 3D and infrared signals emitted from cancerous and benign breast tissue. Results are interpreted by computer, with unprecedented accuracy in patients of all ages — 90 percent as opposed to 80% for mammography. Thousands of women have been involved in clinical trials for RUTH since 2007. The next step is CE and FDA approval.
ISRAEL21c is a website about 21st century Israel which is focussed on Israeli advances in science, health and technology.